ORIGINAL ARTICLE
Grading placental fetal vascular malperfusion and short-term perinatal outcome
More details
Hide details
1
Division of Pathology and Laboratory Medicine, Cincinnati Children’s Hospital Medical Center, Cincinnati, USA
Submission date: 2020-08-23
Acceptance date: 2020-10-07
Publication date: 2021-02-22
Pol J Pathol 2020;71(4):291-300
KEYWORDS
TOPICS
ABSTRACT
This retrospective analysis was performed to seek possible associations of the global fetal vascular malperfusion (GFVM) and grade of segmental fetal vascular malperfusion (SFVM) with early perinatal outcome. Clinical associations of 538 consecutive cases of placental fetal vascular malperfusion (FVM), including 374 cases of SFVM (group 1: 308 low-grade, group 2: 66 high-grade), and 65 cases of GFVM without segmental villous changes (group 3), were statistically compared. Histological SFVM was graded on HE (Subgroups 1A and 2A) and on CD34 or histochemistry stains (segmental endothelial fragmentation, segmental hypovascularity and/or mineralization) (subgroups 1B and 2B). The short term neonatal outcome as evaluated by NICU stay and neurological complications was statistically significantly more frequently complicated in association with high-grade SFVM than in low-grade SFVM and GFVM in general, and equally frequently in high-grade SFVM diagnosed on HE slides only and on CD34 immunostain and/or mineralization histochemistry only (about 61% of cases each). High-grade SFVM portends a more complicated short-term perinatal outcome than low-grade SFVM or GFVM. CD34 immunohistochemistry and/or mineralization histochemistry diagnosed/upgraded high-grade SFVM has the same short-term prognostic significance as high-grade SFVM diagnosed on HE only, thus increasing the sensitivity of placental examination for FVM by these methods.
REFERENCES (38)
1.
Korteweg FJ, Jaap J, Erwich JJHM, et al. Evaluation of 1025 fetal deaths: proposed diagnostic workup. Am J Obstet Gynecol 2012; 206: 53.e1-12.
2.
Ptacek I, Sebire NJ, Man JA, et al. Systematic review of placental pathology reported in association with stillbirth. Placenta 2014; 35: 552-562.
3.
The Stillbirth Collaborative Research Network Writing Group. Causes of death among stillbirths. JAMA 2011; 306: 2459-2468.
4.
Boyd TH, Roberts DJ, Heerema-McKenney A. Fetal vascular malperfusion. In: Khong TY, Mooney EE, Nikkels PGJ, et al. (eds.). Pathology of the Placenta. Springer 2019; 173.
5.
Simcox LE, Ormesher L, Tower C, et al. Thrombophilia and pregnancy complications. Int J Mol Sci 2015; 16: 28418-28428.
6.
Ernst LM. Distal villous lesions associated with fetal vascular occlusion. In: Heerema-McKenney A, Popek EJ, DePaepe ME (eds.). Diagnostic pathology: placenta. Amirsys, Elsevier, Philadelphia 2015; II-6-8.
7.
Khong TY, Mooney EE, Ariel I, et al. Sampling and definitions of placental lesions. Amsterdam placental workshop group consensus statement. Arch Pathol Lab Med 2016; 140: 698-713.
8.
Chang KTE, Keating S, Costa S, et al. Third trimester stillbirths: correlative neuropathology and placental pathology. Pediatr Dev Pathol 2011; 14: 345-352.
9.
Dahms BB, Boyd T, Redline RW. Severe perinatal liver disease associated with fetal thrombotic vasculopathy. Pediatr Dev Pathol 2002; 5: 80-85.
10.
Redline RW, Wilson-Costello D, Borawski E, et al. Placental lesions associated with neurologic impairment and cerebral palsy in very low-birth-weight infants. Arch Pathol Lab Med 1998; 122: 1091-1098.
11.
Vik T, Redline R, Nelson KB, et. The placenta in neonatal encephalopathy. J Pediatr 2018; 202: 77-85.
12.
Stanek J, Biesiada J. Clustering and classical analysis of clinical and placental phenotypes in fetal growth restriction and constitutional fetal smallness. Placenta 2016; 42: 93-105.
13.
Stanek J, Sheridan RM, Le LD, et al. Placental fetal thrombotic vasculopathy in severe congenital anomalies prompting EXIT procedure. Placenta 2011; 32: 373-379.
14.
Lepais L, Gaillot-Durand L, Boutitie F, et al. Fetal thrombotic vasculopathy is associated with thromboembolic events and adverse perinatal outcome but not with neurologic complications: A retrospective cohort study of 54 cases with a 3-year follow-up of children. Placenta 2014; 35: 611-617.
15.
Ernst LM, Bit-Ivan EN, Miller ES, et al. Stillbirth: correlation between brain injury and placental pathology. Pediatr Dev Pathol 2016; 19: 237-243.
16.
Chan JSY, Baergen RN. Gross umbilical cord complications are associated with placental lesions of circulatory stasis and fetal hypoxia. Pediatr Dev Pathol 2012; 15: 487-494.
17.
Redline RW. Clinical and pathological umbilical cord abnormalities in fetal thrombotic vasculopathy. Hum Pathol 2004; 35: 1494-1498.
18.
Battarbee AN, Palatnik A, Ernst LM, et al. Placental abnormalities associated with single umbilical artery in small-for-gestational age births. Placenta 2017; 59: 9-12.
19.
Stanek J. Association of coexisting morphological umbilical cord abnormality and clinical cord compromise with hypoxic and thrombotic placental histology. Virchows Arch 2016; 468: 723-732.
20.
Stanek J. Hypoxic patterns of placental injury: A review. Arch Pathol Lab Med 2013; 137: 706-720.
21.
Stanek J. Segmental villous mineralization: a placental feature of fetal vascular malperfusion. Placenta 2019; 86: 20-27.
22.
Stanek J, Abdaljaleel M. CD34 immunostain increases the sensitivity of placental diagnosis of fetal vascular malperfusion in stillbirth. Placenta 2019; 77: 30-38.
23.
Baergen RN. Cord abnormalities, structural lesions, and cord “accidents”. Sem Diagn Pathol 2007; 24: 23-32.
24.
Heider A. Fetal vascular malperfusion. Arch Pathol Lab Med 2017; 141: 1484-1489.
25.
Stanek J. Placental examination in nonmacerated stillbirth versus neonatal mortality. J Perinat Med 2018; 46: 323-331.
26.
Stanek J. Placental haemosiderosis. Pathology 2010; 42: 499-501.
27.
Stanek J, Biesiada J. Clustering of maternal/fetal clinical conditions and outcomes and placental lesions. Am J Obstet Gynecol 2012; 206: 493.a9.
28.
Stanek J. Histological features of shallow placental implantation unify early onset and late onset preeclampsia. Pediatr Dev Pathol 2019; 22: 112-122.
29.
Stanek J, Weng E. Microscopic chorionic pseudocysts in placental membranes: a histologic lesion of in utero hypoxia. Pediatr Dev Pathol 2007; 10: 192-198.
30.
Stanek J. Chorionic disc extravillous trophoblasts in placental diagnosis. Am J Clin Pathol 2011; 136: 540-547.
31.
McDermott M, Gillan JE. Trophoblast basement membrane haemosiderosis in the placental lesion of fetal artery thrombosis: a marker for disturbance of maternofetal transfer. Placenta 1995; 16: 171-178.
32.
Stanek J. Fetal vascular malperfusion. Arch Pathol Lab Med 2018; 142: 679-680.
33.
Genest DR. Estimating the time of death in stillborn foetuses: II. Histologic evaluation of the placenta; a study of 71 stillborns. Obstet Gynecol 1992; 80: 585-592.
34.
Redline RW, Ravishankar S. Fetal vascular malperfusion, an update. APMIS 2018; 126: 561-569.
35.
Opsjøn BE, Vogt C. Explaining fetal death-what are the contributions of fetal autopsy and placenta examination? Pediatr Dev Pathol 2016; 19: 24-30.
36.
Stanek J. Patterns of placental injury in congenital anomalies in second half of pregnancy. Pediatr Dev Pathol 2019; 22: 513-522.
37.
Mir IN, Chalak LF, Brown LS, et al. Impact of multiple placental pathologies on neonatal death, bronchopulmonary dysplasia, and neurodevelopmental impairment in preterm infants. Pediatr Res 2020; 87: 885-891.
38.
Jacques SM, Kupsky WJ, Giorgadze T, et al. Fetal central nervous system injury in third trimester stillbirth: a clinicopathologic study of 63 cases. Pediatr Dev Pathol 2012; 15: 375-384.